Abstract | BACKGROUND: OBJECTIVE: PATIENTS & METHODS: This study was conducted at the Department of Dermatology & Venereology, Baghdad Teaching Hospital. Twenty-eight patients with melasma were treated with 10% zinc sulfate solution. Every patient was instructed to apply the formula twice daily and to be seen every 2 weeks for 2 months. The severity of melasma was assessed before, during, and after treatment with the melasma area and severity index (MASI). All patients were instructed to apply a broad-spectrum sunscreen with SPF>30 before sun exposure during treatment and for the 3-month follow-up period. RESULTS: Fourteen patients were treated with 10% zinc sulfate solution. The mean MASI score before treatment was 9.45, which changed to 4.70 after therapy. This corresponds to a percentage improvement of 49.78% and was statistically significant (p<.0005). No side effects were reported apart from a mild stinging sensation reported in a few patients. Most patients maintained improvement 3 months after cessation of therapy. CONCLUSION:
|
Authors | Khalifa E Sharquie, Sabeeh A Al-Mashhadani, Hussam A Salman |
Journal | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
(Dermatol Surg)
Vol. 34
Issue 10
Pg. 1346-9
(Oct 2008)
ISSN: 1524-4725 [Electronic] United States |
PMID | 18616534
(Publication Type: Journal Article)
|
Chemical References |
- Dermatologic Agents
- Zinc Sulfate
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Dermatologic Agents
(administration & dosage)
- Female
- Humans
- Male
- Melanosis
(drug therapy)
- Middle Aged
- Treatment Outcome
- Young Adult
- Zinc Sulfate
(administration & dosage)
|